-
Founded in:
2009-07-24 -
Country:
China -
Address:
Houyi Development Zone, Yongqing County, Langfang City, Hebei Province (west of Lifengxian Village) -
Tax NO.:
911310236920791262 -
Registered Funds:
30 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nilestriol |
The above information does not clearly mention the specific pharmacological effects
More
The above information does not clearly mention the specific pharmacological effects |
39791-20-3 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nilestriol |
Estrogen drugs. This product is a derivative of estriol. Its pharmacological effects are similar to those of estradiol, but its biological activity is low, so its effect on endometrial proliferation is also weak. It is suitable for estrogen replacement therapy for perimenopausal women. The introduction of cyclopentyl ether at the 3rd position increases its lipophilicity, which is beneficial for intestinal absorption and storage in adipose tissue, and then slowly released to play a long-term effect. The introduction of acetylene at the 17th position enhances the estrogen activity.
More
Estrogen drugs. This product is a derivative of estriol. Its pharmacological effects are similar to those of estradiol, but its biological activity is low, so its effect on endometrial proliferation is also weak. It is suitable for estrogen replacement therapy for perimenopausal women. The introduction of cyclopentyl ether at the 3rd position increases its lipophilicity, which is beneficial for intestinal absorption and storage in adipose tissue, and then slowly released to play a long-term effect. The introduction of acetylene at the 17th position enhances the estrogen activity. |
39791-20-3 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nilestriol |
Estrogen drugs. This product is a derivative of estriol. Its pharmacological effects are similar to those of estradiol, but its biological activity is low, so its effect on endometrial proliferation is also weak. It is suitable for estrogen replacement therapy for perimenopausal women. The introduction of cyclopentyl ether at the 3rd position increases its lipophilicity, which is beneficial for intestinal absorption and storage in adipose tissue, and then slowly released to play a long-term effect. The introduction of acetylene at the 17th position enhances the estrogen activity.
More
Estrogen drugs. This product is a derivative of estriol. Its pharmacological effects are similar to those of estradiol, but its biological activity is low, so its effect on endometrial proliferation is also weak. It is suitable for estrogen replacement therapy for perimenopausal women. The introduction of cyclopentyl ether at the 3rd position increases its lipophilicity, which is beneficial for intestinal absorption and storage in adipose tissue, and then slowly released to play a long-term effect. The introduction of acetylene at the 17th position enhances the estrogen activity. |
39791-20-3 | 2 |